Inspire Medical Systems, Inc. to Report First Quarter 2019 Financial Results on May 7, 2019

Download as PDF

MINNEAPOLIS – April 9, 2019 – Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical
technology company focused on the development and commercialization of innovative and minimally
invasive solutions for patients with obstructive sleep apnea, today announced that it will release financial
results for the first quarter 2019 after the close of trading on Tuesday, May 7. Inspire’s management team
will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial
results and recent business developments.

Tuesday, May 7th @ 5:00 p.m. Eastern Time:
Domestic: 877-407-0792
International: 201-689-8263
Conference ID: 13688690
Webcast: http://public.viavid.com/index.php?id=133632

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of
innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s
proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides
a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact:
Bob Yedid
LifeSci Advisors
inspire@lifesciadvisors.com
646-597-6989